Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
BioBlast®
Biosimilars Deals 2023
Biosimilars Deals 2024
Chris Vindurampulle
Diversity
Masterclasses
Other Podcasts
Other Updates
Our Awards
Patent Case Summaries
Patent Litigation
Patents
Paul Johns
PipCast®
PTE
Trade Marks
Webinars
Robin Smith LR Colour

Robin Smith

Executive Officer

Robin is Pearce IP’s Executive Officer, supporting our CEO. Robin is dedicated and enthusiastic, having worked in high pressure professional settings over many years, and is seasoned at maintaining professionalism whilst meeting the needs of busy executives in such environments.

Robin has previously supported the CEO and departmental leads of a finance company. Prior to that, Robin worked at Channel 9 as a Supervising Director’s Assistant, responsible for managing and rostering a team of full time and freelance staff, while providing graphics, timings and support for key stakeholders involved in live programs. Robin has also worked for Fox Sports, BusterDandy/ABC/UK Disney Channel, Southern Star, Network 7, and the BBC in London.

Robin uses her experience and professionalism to further the success of Pearce IP.

Pearce IP Awards

Chambers and Partners

Intellectual Property (2024)

Legal 500 Asia Pacific

Market Leading Intellectual Property Firm (2024)
Market Leading Intellectual Property Firm (2023)

IAM Patent 1000

Bronze for litigation (20232022, 2021)
Bronze for prosecution (2024, 20232022, 2021)

Australian Law Awards (Lawyers Weekly)

Finalist – Women in Law Awards – Boutique Diversity Firm of the Year (2022)
Finalist – Intellectual Property Team of the Year (2022)
Winner – Intellectual Property Team of the Year (2021)

Managing IP Stars

Patent Prosecution (2024, 2023, 2022)
The Only Leading Female Owned Life Sciences focussed IP Firm (2023)
Pearce IP ranked firm (2021)

Women in Business Law Awards - APAC

Shortlisted – Australian Firm of the Year (2022)

Lexology Legal Influencer

Australasia – Healthcare and Life Sciences (Q2 2024, Q1 2024, Q4 2023, Q3 2023, Q2 2023, Q3 2022, Q2 2022, Q1 2021, Q4 2020)

Cross-border – Healthcare and Life Sciences (Q2 2024, Q1 2024, Q4 2023, Q3 2023, Q2 2023, Q1 2023)

Australasian Lawyer

Top Boutique Firm (2024)
5-Star Intellectual Property Law Firm (2021)

Doyles Intellectual Property

Doyles Leading Intellectual Property (2021, 2020)
Doyles Recommended Intellectual Property (2021)

"Winner - Intellectual Property Team of the Year 2021"

Australian Law Awards (Lawyers Weekly)

"Finalist - Intellectual Property Team of the Year 2022"

Australian Law Awards (Lawyers Weekly)

"Pearce IP bronze ranking for litigation and recommended for prosecution"

IAM Patent 1000 2021

"Pearce IP ranked bronze for litigation and prosecution"

IAM Patent 1000 2022

"5-Star Intellectual Property Law Firm"

Australasian Lawyer 5-Star Awards 2021

"Pearce IP Ranked Tier 3 - Prosecution"

MIP IP Stars 2022

"Women in Business Law Awards - APAC"

Shortlisted: Australian Firm of the Year (2022)

"Lexology Legal Influencer"

Healthcare and Life Sciences (Australasia): Pearce IP (Q2 2022, Q1 2021, Q4 2020)

Healthcare and Life Sciences (Cross-border): Pearce IP (2021)

The Legal 500, 2023, Intellectual Property, Australia

The Pearce IP team has an in depth understanding of the science and the pharmaceutical regulatory industry driving many of their client’s businesses.  They are passionate about achieving their client’s commercial objectives – and they are extremely hard-working and dedicated lawyers.

OUR VISION

By 2027, be the premier life sciences IP practice in
Australia and New Zealand.